Current disease status-First occurrence of the cancer - Page 30 of 59 Posts on Medivizor
Navigation Menu

Current disease status-First occurrence of the cancer Posts on Medivizor

Dealing with cancer pain: Low-dose morphine examined

Dealing with cancer pain: Low-dose morphine examined

Posted by on Feb 6, 2016 in Melanoma | 0 comments

In a nutshell This study compared weak opioids and low-dose morphine in providing pain relief for moderate cancer pain. Researchers concluded that low-dose morphine is more suitable as pain management for moderate cancer pain than weaker pain relievers. Some background The guidelines for cancer pain relief developed by the World Health...

Read More

Should hormone therapy be added to intensive radiotherapy in early prostate cancer?

Should hormone therapy be added to intensive radiotherapy in early prostate cancer?

Posted by on Jan 31, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the potential benefit of early hormone therapy added to intensive radiotherapy in the treatment of men with intermediate-risk local prostate cancer. Overall survival was found to be improved with higher radiation dosage. However, the researchers noted that early hormone therapy does generally not benefit treatment...

Read More

Can toremifene improve the effectiveness of androgen-deprivation therapy?

Can toremifene improve the effectiveness of androgen-deprivation therapy?

Posted by on Jan 25, 2016 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the effect of toremifene (Fareston) and raloxifene (Evista) when added to hormone therapy in prostate cancer patients who had not received previous treatments. The authors concluded that toremifene and hormone therapy significantly improved the rate of biochemical recurrence (BCR, a rise in prostate...

Read More

Factors associated with disease progression

Factors associated with disease progression

Posted by on Dec 20, 2015 in Breast cancer | 0 comments

In a nutshell This study explored factors that could predict disease progression following chemotherapy in breast cancer patients. The authors found that while survival rates were excellent following treatment, patients with faster-growing tumors and those with the luminal B/HER negative or triple negative subtypes had a higher risk of disease...

Read More

Pain relief for bone metastasis in prostate cancer

Pain relief for bone metastasis in prostate cancer

Posted by on Dec 14, 2015 in Prostate cancer | 0 comments

In a nutshell This study compared the effectiveness of ibandronate (Boniva) with the more conventional radiotherapy in reducing metastatic bone pain in prostate cancer. Some background Bone metastasis (cancer spread to the bone) is a common and painful occurrence in prostate cancer. There are a range of treatments available, with radiotherapy...

Read More

What is the best treatment for patients with rectal cancer after chemotherapy, radiation and surgery?

What is the best treatment for patients with rectal cancer after chemotherapy, radiation and surgery?

Posted by on Nov 30, 2015 in Colorectal cancer | 0 comments

In a nutshell This study compared the effectiveness of oxaliplatin (Eloxatin) with 5-fluorouracil (5-FU Oncofluor, Fluorblastin) as post-surgery treatment for patients with rectal cancer.  Some background The standard treatment for rectal cancer is chemotherapy and radiation therapy before surgery. The effectiveness of post-surgery...

Read More

How often are bisphosphonates required in breast cancer that has spread to the bone?

How often are bisphosphonates required in breast cancer that has spread to the bone?

Posted by on Nov 30, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to evaluate the benefit of reducing the dosage of bisphosphonate therapy (such as Fosamax or Reclast) for women with bone metastasis (the original cancer has spread to the bones). Some background Bisphosphonate therapy is a treatment used to prevent the loss of bone mass. Women who have developed bone...

Read More

New type of surgery improves survival without disease in colon cancer patients

New type of surgery improves survival without disease in colon cancer patients

Posted by on Nov 23, 2015 in Colorectal cancer | 0 comments

In a nutshell This study compared the disease-free survival rates of patients who had a complete mesocolic excision with patients who had conventional surgery for treatment of colon cancer. Some background Patients with rectal cancer have higher survival rates than colon cancer patients. This is in part due to the type of surgery carried out. Many...

Read More